The CEO of Arena Pharmaceuticals says he’s very pleased by clinical trial results for the company’s weight-loss drug, despite negative reaction from investors. KPBS Reporter Tom Fudge has more.
More: continued here
If you like this post, please buy me a beer for $3 8-)
Blogsphere: TechnoratiFeedsterBloglines
Bookmark: Del.icio.usSpurlFurlSimpyBlinkDigg
RSS feed for comments on this post | TrackBack URI for this post


















